Evolution of Clinical Pharmacy in the Practice of Rheumatology
暂无分享,去创建一个
[1] J. Esdaile,et al. Improving osteoarthritis detection in the community: pharmacist identification of new, diagnostically confirmed osteoarthritis. , 2007, Arthritis and rheumatism.
[2] J. Sim,et al. Effectiveness of community physiotherapy and enhanced pharmacy review for knee pain in people aged over 55 presenting to primary care: pragmatic randomised trial , 2006, BMJ : British Medical Journal.
[3] F. Pucino,et al. Use of biologics in rheumatoid arthritis: where are we going? , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[4] B. Resman-Targoff. Medical therapy: where are we now? , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[5] T. Moger,et al. Interview of patients by pharmacists contributes significantly to the identification of drug‐related problems (DRPs) , 2006, Pharmacoepidemiology and drug safety.
[6] P. Richette,et al. Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinol , 2006, Nature Clinical Practice Rheumatology.
[7] J. Cooper,et al. Pharmacist interventions in geriatric nursing facility NSAID therapy: a one-year follow-up study of costs and outcomes. , 2005, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.
[8] J. Brouwers,et al. A costly therapeutic dilemma in tophaceous gout: is etanercept or rasburicase preferable? , 2005, Annals of the rheumatic diseases.
[9] R. Fleischmann. Is there a need for new therapies for rheumatoid arthritis? , 2005, The Journal of rheumatology. Supplement.
[10] P. Lipsky,et al. New concepts in the treatment of rheumatoid arthritis. , 2003, Annual review of medicine.
[11] J. Stoner,et al. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial. , 2002, Arthritis and rheumatism.
[12] S. Mehta,et al. Health outcomes assessment in community pharmacy practices: a feasibility project. , 2002, Arthritis and rheumatism.
[13] S. Dedhiya,et al. Use of Point‐of‐Service Health Status Assessments by Community Pharmacists to Identify and Resolve Drug‐Related Problems in Patients with Musculoskeletal Disorders , 2001, Pharmacotherapy.
[14] L. Callahan,et al. The Arthritis Foundation 1948-1998: 50 years of arthritis care and research. , 1998, Arthritis care and research : the official journal of the Arthritis Health Professions Association.
[15] Luis A. Rodriguez. Variability in risk of gastrointestinal complications with different nonsteroidal anti-inflammatory drugs. , 1998 .
[16] E. Kay. The changing role of the clinical pharmacist in rheumatology. , 1986, British journal of rheumatology.
[17] R. O. Day. Variability in response to NSAIDs: what progress? , 1993, Agents and actions. Supplements.
[18] Methotrexate in rheumatoid arthritis. Health and Public Policy Committee, American College of Physicians. , 1987, Annals of internal medicine.